gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline. Antimicrob Agents Chemother 2013; 57: 4042–5. 11 Luther M, Rice LB, LaPlante KL. Dual b-lactam activity against Enterococcus faecalis in a high inoculum in vitro pharmacodynamic (IVPD) bacteremic model. In: Abstracts of the Fifty-fourth Interscienc
Two cases of endocarditis, one caused by high-level gentamicin-resistant Enterococcus durans and the...
BACKGROUND: In 2004-2008, the epidemiological and clinical Infective Endocarditis Study Group (SEI) ...
<p>Nine strains of <i>Enterococcus faecalis</i> were used, including: 6 clinical strains obtained fr...
A recurrent case of left-sided endocarditis caused by high-level aminoglycoside-resistant Enterococc...
Enterococci are the thirdmost frequent cause of infective endocarditis. A high-inoculum stationary-p...
Abstract Enterococci are the third most frequent cause of infective endocarditis. A high-24 inoculum...
The frequency of infective endocarditis (IE) has increased 3 times over the past 30 years. The incid...
Ampicillin-ceftriaxone combination therapy has become a predominant treatment for serious Enterococc...
Enterococci are the third most frequent cause of infective endocarditis. A high-inoculum stationary-...
Enterococcus faecalis (E. faecalis) has become a major leading cause of nosocomial endocarditis. Tre...
Ceftobiprole (BAL9141) is an investigational cephalosporin with broad in vitro activity against gram...
2 Ceftobiprole (BAL9141) is an investigational cephalosporin with broad in vitro activity against Gr...
doi:10.1093/jac/dkl406 Efficacy of daptomycin in the treatment of experimental endocarditis due to s...
<p>Nine strains of <i>Enterococcus faecalis</i> were used, including: 6 clinical strains obtained fr...
The case of a patient with highly gentamicin-resistant Enterococcus faecalis endocarditis treated wi...
Two cases of endocarditis, one caused by high-level gentamicin-resistant Enterococcus durans and the...
BACKGROUND: In 2004-2008, the epidemiological and clinical Infective Endocarditis Study Group (SEI) ...
<p>Nine strains of <i>Enterococcus faecalis</i> were used, including: 6 clinical strains obtained fr...
A recurrent case of left-sided endocarditis caused by high-level aminoglycoside-resistant Enterococc...
Enterococci are the thirdmost frequent cause of infective endocarditis. A high-inoculum stationary-p...
Abstract Enterococci are the third most frequent cause of infective endocarditis. A high-24 inoculum...
The frequency of infective endocarditis (IE) has increased 3 times over the past 30 years. The incid...
Ampicillin-ceftriaxone combination therapy has become a predominant treatment for serious Enterococc...
Enterococci are the third most frequent cause of infective endocarditis. A high-inoculum stationary-...
Enterococcus faecalis (E. faecalis) has become a major leading cause of nosocomial endocarditis. Tre...
Ceftobiprole (BAL9141) is an investigational cephalosporin with broad in vitro activity against gram...
2 Ceftobiprole (BAL9141) is an investigational cephalosporin with broad in vitro activity against Gr...
doi:10.1093/jac/dkl406 Efficacy of daptomycin in the treatment of experimental endocarditis due to s...
<p>Nine strains of <i>Enterococcus faecalis</i> were used, including: 6 clinical strains obtained fr...
The case of a patient with highly gentamicin-resistant Enterococcus faecalis endocarditis treated wi...
Two cases of endocarditis, one caused by high-level gentamicin-resistant Enterococcus durans and the...
BACKGROUND: In 2004-2008, the epidemiological and clinical Infective Endocarditis Study Group (SEI) ...
<p>Nine strains of <i>Enterococcus faecalis</i> were used, including: 6 clinical strains obtained fr...